IN THE UNITED STATES PATENT AND TRADEMARK OFFICE
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`DR. REDDY’S LABORATORIES, LTD.
`AND DR. REDDY’S LABORATORIES, INC.,
`Petitioners,
`
`v.
`
`INDIVIOR UK LIMITED
`(F/K/A RB PHARMACEUTICALS LIMITED),
`Patent Owner.
`
`Case No. IPR2016-01113
`Patent No. 8,475,832
`
`
`
`
`
`
`
`
`
`
`
`
`
`PATENT OWNER INDIVIOR UK LIMITED’S UPDATED EXHIBIT LIST
`
`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`DR. REDDY’S LABORATORIES, LTD.
`AND DR. REDDY’S LABORATORIES, INC.,
`Petitioners,
`
`v.
`
`INDIVIOR UK LIMITED
`(F/K/A RB PHARMACEUTICALS LIMITED),
`Patent Owner.
`
`Case No. IPR2016-01113
`Patent No. 8,475,832
`
`
`
`
`
`
`
`
`
`
`
`
`
`PATENT OWNER INDIVIOR UK LIMITED’S UPDATED EXHIBIT LIST
`
`
`
`
`IPR2016-01113
`
`LIST OF EXHIBITS
`
`Description
`Redline comparison of Teva IPR2016-00280 Petition and Dr.
`Reddy’s IPR2016-01113 Petition
`Redline comparison of Teva IPR2016-00280 Declaration of Dr. Das
`and Dr. Reddy’s IPR2016-01113 Declaration of Dr. Celik
`Dr. Reddy’s to acquire product portfolio from TEVA for US Market,
`Press Release, Dr. Reddy’s Laboratories Ltd., June 11, 2016
`Email from Dr. Reddy’s counsel summarizing meet and confer
`teleconference conducted July 6, 2016
`Teva/Allergan Divestiture Products Table, Docket No. C-4589
`(F.T.C. July 27, 2016)
`FTC Requires Teva to Divest Over 75 Generic Drugs to Settle
`Competition Concerns Related to its Acquisition of Allergan’s
`Generic Business, Press Release, Federal Trade Commission (July
`27, 2016), https://www.ftc.gov/news-events/press-
`releases/2016/07/ftc-requires-teva-divest-over-75-generic-drugs-
`rival-firms-settle
`PTAB Telephonic Conference Transcript, IPR2016-01111,
`IPR2016-01112, IPR2016-01113 (August 1, 2016)
`Carl O’Donnell, Teva Pharm finalizing asset sales to clear Allergan
`deal - source, Reuters (May 5, 2016),
`http://www.reuters.com/article/allergan-ma-teva-pharm-ind-assets-
`idUSL2N1820VD
`Carl O’Donnell, Teva Pharm finalizing asset sales to clear Allergan
`deal - source, Reuters (May 5, 2016),
`http://www.reuters.com/article/allergan-ma-teva-pharm-ind-assets-
`idUSL2N1820VD
`Nandita G. Das & Sudip K. Das, Development of Mucoadhesive
`Dosage Forms of Buprenorphine for Sublingual Drug Delivery, 11
`Drug Delivery 89 (2004)
`Priya Batheja et al., Basic Biopharmaceutics of Buccal and
`Sublingual Absorption, in Enhancement in Drug Delivery 175, 182
`(Elka Touitou & Brian W. Barry eds. 2006)
`David S. Weinberg et al., Sublingual absorption of selected opioid
`analgesics, 71 Clinical Pharmacology & Therapeutics 335 (1988)
`John Mendelson et al., Bioavailability of Sublingual Buprenorphine,
`37 J. Clinical Pharmacology 31 (1997)
`
`Exhibit
`2001
`
`2002
`
`2003
`
`2004
`
`2005
`
`2006
`
`2007
`
`2008
`
`2008
`
`2009
`
`2010
`
`2011
`
`2012
`
`
`
`1
`
`
`
`IPR2016-01113
`
`Jinsong Hao & Paul W.S. Heng, Buccal Delivery Systems, 29(8)
`Drug Development & Industrial Pharmacy 821 (2003)
`S.A. Robertson, PK-PD modeling of buprenorphine in cats:
`intravenous and oral transmucosal administration, 28(5) Journal of
`Veterinary Pharmacology and Therapeutics 453 (2005)
`Yamamoto et al., Absorption of water-soluble compounds with
`different molecular weights and [Asu1.7]-eel calcitonin from various
`mucosal administration sites, 76 J. Controlled Release 363 (2001)
`Amir H. Shojaei, Buccal Mucosa as a Route for Systemic Drug
`Delivery: A Review, 1(1) J. Pharmacy & Pharmaceutical Sci. 15
`(1998)
`Rakesh Hooda et al., A Review on Oral Mucosal Drug Delivery
`System, 1(1) Pharma Innovation 14 (2012)
`N.V. Satheesh Madhav, Orotransmucosal Drug Delivery Systems: A
`Review, 140 J. Controlled Release 2 (2009)
`U.S. Patent No. 7,331,251
`Swatantra K.S. Kushwaha et al., Advances in Nasal Trans-Mucosal
`Drug Delivery, 1(7) J. Applied Pharmaceutical Sci. 21 (2011)
`Javier O. Morales & Jason T. McConville, Manufacture and
`Characterization of Mucoadhesive Buccal Films, 77 Eur. J.
`Pharmaceutics and Biopharmaceutics 187 (2011)
`Thakur Smriti, Mouth Dissolving Films: A Review, 4(1) Int’l J.
`Pharma and Bio Sciences P-899 (2013)
`Heiko Tietgen, Physicochemical Properties, in Drug Discovery and
`Evaluation: Safety and Pharmacokinetic Assays 399 (Hans Gerhard
`Vogel et al. eds., 2006)
`Ulrika Espefalt Westin, Olfactory Transfer of Analgesic Drugs After
`Nasal Administration (Dissertation, Uppsala University 2007)
`Ulrike Werner, In Situ Gelling Nasal Inserts for Prolonged Drug
`Delivery (Dissertation, Free University Berlin 2003)
`Email correspondence between counsel for Patent Owner &
`Petitioner, September 8-9, 2016
`
`2013
`
`2014
`
`2015
`
`2016
`
`2017
`
`2018
`
`2019
`2020
`
`2021
`
`2022
`
`2023
`
`2024
`
`2025
`
`2026
`
`
`
`
`
`2
`
`
`
`Date: September 14, 2016
`
`Respectfully submitted,
`
`IPR2016-01113
`
`
`
`,/
`
`By ix /:9
`
`{W
`
`Andrea G. Reisger
`Registration No. 36,253
`Enrique D. Longton
`Registration No. 47,304
`COVINGTON & BURLING LLP
`
`One CityCenter, 850 Tenth Street, NW
`Washington, DC 20001
`(202) 662-6000
`Attorneys for Patent Owner
`
`
`
`IPR2016-01113
`
`CERTIFICATE OF SERVICE
`
`Pursuant to 37 C.F.R. § 42.6, I hereby certify that on this 14th day of
`
`September 2016,
`
`the foregoing Patent Owner Indivior UK Lirnited’s Updated
`
`Exhibit List,
`
`together with Exhibit 2026, was served by electronic mail, by
`
`agreement of the parties, on the following counsel of record for petitioner.
`
`Jeffrey B. Arnold (jarnold@cantorcolburn.com)
`Peter R. Hagerty (phagerty@cantorcolburn.com)
`Leslie-Ann Maxwell, Ph.D. (amaxwell@cantorcolburn.com)
`Andrew C. Ryan (ryan@cantorcolburn.com)
`Cantor Colburn LLP
`
`Date: September 14, 2016
`
` {jg
`
`Andrea G. Re ster, Esq.
`Registration No.: 36,253
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ Charge
Still Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site
